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AB0734 EVALUATION OF CARDIOVASCULAR RISK PROFILES IN A POPULATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS: A CROSS-SECTIONAL STUDY
2 ). AS patients had significantly lower levels of HDL and TC and a higher level of CRP and atherogenic index (TC/HDL, ApoB/ApoA). AS patients had higher CV mortality than controls (1.1±1.8 vs 0,51±1.13%, p=0.01). The frequency of high cardiovascular risk was higher in AS patients (5 vs 2, p=0.4). The correlation between SCORE's risk and biological markers were positive with TC, LDL, Lp (a), TC/HDL ratio and LDL/HDL ratio. Conclusions: AS patients are at a greater cardiovascular risk due to a higher CRP rate, atherogenic index and 10-year risk SCOREs of CV mortality. So, the dyslipidaemia and inflammation could be the aetiology of cardiovascular risk. 
Background:
According to modern conception "T2T" a patient with ankylosing spondylitis (AS) takes an active part in the disease treatment that determines the importance of his psychological state. Objectives: To evaluate interconnection between the psychological state of the patient with AS and the disease course.
Methods: Within the regional registry which is a part of epidemiological study of clinical diversity of AS in Russian population, 40 patients (32 males and 8 females) at the age of 21 to 56 years (average age 40,3±10,0) were examined. The average disease duration on the day of examination was 12,7±9,9 years, BASDAI -5,54±1,8, BASFI -5,34±2,48. Functional status (range of motion) was evaluated by means of BASMI. EQ-5D questionnaire was used for psychological state evaluation. Results: A total of 17 (42,5%) patients had anxiety and depression: moderate -15 (88,2%), severe -2 (11,8%) responders. With the disease duration of less than 5 years propensity for depression and anxiety was noted by 6 out of 11 (54,5%) patients, 5 to 10 years -2 out of 12 (16,7%), more than 10 years -9 out of 17 (52,9%). In patients with mild disease activity anxious and depressive states were not observed, with moderate disease activity they were revealed in 3 out of 7 patients (42,8%), with severe activity -in 9 out of 21 (42,8%), with very severe activityin 5 out of 10 (50%) responders. Among the patients without limitation of motion (BASFI) anxiety and depression was revealed in 2 out of 11 (18,2%), with moderate limitation -6 out of 18 (33,3%), with severe limitation -9 out of 11 (81,8%) patients. According to BASMI 1 out of 2 patients without limitation of motion had anxiety and depression, 6 out of 19 (31,5%) -with moderate limitation and 10 out of 19 (52,6%) with severe limitation. The direct correlation was revealed between EQ-5D score and BASFI (r=0,996) and between EQ-5D and BASDAI (r=0,855), concurrently such correlation was absent between BASMI and EQ-5D. Among the patients without anxious and depressive states 14 out of 23 (60,8%) patients take NSAIDs regularly while among the patients who noted propensity for anxiety and depression only 7 out of 17 (41,17%) take NSAIDs regularly. Conclusions: Patients with short (less than 5 years) and long (more than 10 years) AS duration, severe disease activity and functional limitation are more prone to anxiety and depression. Patients with anxious and depressive states are less compliant with therapy which influences its efficacy. These data should be considered when the programs of AS patients' management are developed. Background: Pulse Wave Velocity (PWV) is the main determinant of arterial stiffness. In recent years the increased arterial stiffness in Ankylosing Spondylitis was shown [1] . The most of investigations of arterial stiffness in ankylosing spondylitis were performed on the treatment by anti TNF-therapy [2] . However, today this issue has not been adequately studied. Objectives: To evaluate the data of central aortic pressure and PWV and their relationship with Ankylosing Spondylitis. Methods: 49 patients with Ankylosing Spondylitis aged between 19 and 60 (mean age 39.6±10.6) were examined. This group (group 1) included 38 men, 11 woman. Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP) was 3.11±0.55. Duration of Ankylosing Spondylitis was from 0.5 to 20 years (mean 5.87±4.76 years). X-ray stage sacroiliac joints (according Modified New York Criteria) was 2.59±1.42. The control group included 33 healthy individuals. The groups were similar in age and sex. 10 patients with ankylosing spondylitis have history of arterial hypotension, however, at the time of inclusion in this study their blood pressure was stabilized. The groups did not differ by office blood pressure parameters and heart rate. Indicators of central aortic pressure and PWV were determined by applanation tonometry by SphygmoCor, Australia. For statistical analysis we used Mann-Whitney criteria and Spirmen correlation method. The study was based on GCP principles. Results: Increased levels of central systolic blood pressure (118.02±14.02 vs 101.1±10.2, p=0.00001), central diastolic blood pressure (80.23±11.86 vs 71.8±7.3, p=0,001) were determined in patients with Ankylosing Spondylitis. Patients with Ankylosing Spondylitis demonstrated the increase in central mean pressure compared to control groop on 17.2% (108.5±13.6 vs 92.6±9.4 p=0.0001). Pulse Wave Velocity (PWV) in the carotid-femoral segment in patients with ankylosing spondylitis was 6.5±1.3 m/sec vs 5.2±0.96 m/sec (p=0.0001) in the control group. The levels of augmentation pressure and Subendocardial viability ratio (SERV) were similar in the examined groups. PWV was directly correlated with trangulus-to-wall (r=0,41; p=0,005) and with X-ray stage of sacroiliitis (r=0,31; p=0,043) and negative correlated with Lumbar flexion (Shober test) (r= -0,38; p=0,009). Conclusions: Increasing indicators of arterial stiffness, such as, PWV, central systolic blood pressure, central diastolic blood pressure, central mean pressure were determined in patients with Ankylosing Spondylitis. The relationship between clinical data, X-ray stage and PWV was demonstrated.
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